Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 14, 2019 Off

Global Hypogonadism Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…

June 14, 2019 Off

Global Hypogonadism Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…

June 14, 2019 Off

Global Hypogonadism Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…

June 14, 2019 Off

Global Hypogonadism Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hypogonadism Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…

June 14, 2019 Off

Global Pruritus Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Pruritus Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…

June 14, 2019 Off

Global Pruritus Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Pruritus Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…

June 14, 2019 Off

Global Celiac Disease Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…

June 14, 2019 Off

Global Celiac Disease Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…

June 14, 2019 Off

Global Celiac Disease Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…

June 14, 2019 Off

Aura Biosciences to Present Interim Phase 1b/2 Clinical Data for AU-011 at the European Society of Ophthalmology 2019 Congress

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that interim…

Posts pagination

Previous 1 … 5,693 5,694 5,695 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine